在卵巢癌中准FSH/FSHR轴:使用纳米技术和免疫治疗的先进治疗
Fuqing Feng1, Tianhang Liu1, Xiaoman Hou1
1Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Frontiers in endocrinology
|January 1, 2025
概括
卵泡刺激激素 (FSH) 通过与FSH受体 (FSHRs) 相互作用,促进卵巢癌 (OC) 的生长. 针对这种FSH/FSHR轴,为OC治疗提供了一个有前途的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 卵巢癌 (OC) 的预后不好,在手术和化疗等标准治疗后经常复发.
- 瘤微环境 (TME) 在OC进展中起着至关重要的作用,需要针对瘤细胞及其周围环境的治疗.
- 卵泡刺激激素 (FSH) 水平升高与OC预后较差有关,卵巢癌细胞表达FSH受体 (FSHRs).
研究的目的:
- 审查FSH在正常系统中的生理作用.
- 阐明FSH/FSHR轴在OC增殖,生存和转移中的机制.
- 讨论针对OC治疗中的FSHR的当前和未来战略.
主要方法:
- 对FSH对正常生理学影响的文献综述.
- 对FSH/FSHR轴在卵巢癌进展中的作用的分析.
- 审查FSHR向治疗的最新进展,包括纳米技术和免疫疗法.
主要成果:
- FSH影响生殖,骨,心脏和新陈代谢系统.
- FSH/FSHR轴促进OC细胞的增殖,生存和转移.
- 纳米技术和免疫疗法正在成为针对FSHR的OC治疗的新方法.
结论:
- FSH/FSHR轴是卵巢癌的一个关键驱动因素.
- 准FSHR为OC提供了一个可行的治疗策略.
- 未来的研究应该专注于优化FSHR向疗法,结合纳米技术和免疫疗法以改善结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394


